Trial intelligence / Profile preview

Dose-finding study of estetrol-containing combined oral contraception

NL-OMON27454Active, not recruiting

Sponsor
Estetra S.A. mw. X.Y. Zimmerman p/a Postbus 464 3700 AL Zeist Tel: +31 30 6 985 020 Fax: +31 30 6 985 021 [email protected]
Start
Nov 2009
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of estetrol in contraception (6 arms), sponsored by Estetra S.A. mw. X.Y. Zimmerman p/a Postbus 464 3700 AL Zeist Tel: +31 30 6 985 020 Fax: +31 30 6 985 021 [email protected]. Primary endpoints: Follicle development and ovulation suppression and Biochemical liver parameters. Started Nov 2009; status: active, not recruiting.

02

Drugs

estetrol
03

Conditions

contraception

Beyond the preview

Go deeper on NL-OMON27454.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON27454.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call